UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Drug desensitization to lumacaftor/ivacaftor: A fast lane to drug tolerance

Journal of cystic fibrosis, 2023-09, Vol.22 (5), p.941-943

2023

Volltextzugriff (PDF)

Be flexible when unscrewing: Screw aspiration in a 15‐year‐old girl

Pediatric pulmonology, 2023-04, Vol.58 (4), p.1266-1268

2023

Volltextzugriff (PDF)

Chronic inhaled antibiotic therapy in people with cystic fibrosis with Pseudomonas aeruginosa infection in Germany

Pulmonary pharmacology & therapeutics, 2023-06, Vol.80, p.102214-102214, Article 102214

2023

Volltextzugriff (PDF)

Risk factors for cystic fibrosis arthropathy: Data from the German cystic fibrosis registry

Journal of cystic fibrosis, 2021-11, Vol.20 (6), p.e87-e92

2021

Volltextzugriff (PDF)

Concordant genotype of upper and lower airways P aeruginosa and S aureus isolates in cystic fibrosis

Thorax, 2009-06, Vol.64 (6), p.535-540

2009

Volltextzugriff (PDF)

ECFS standards of care on CFTR-related disorders: Towards a comprehensive program for affected individuals

Journal of cystic fibrosis, 2024-05, Vol.23 (3), p.388-397

2024

Volltextzugriff (PDF)

P063 Survival analysis of the German Cystic Fibrosis Registry

Journal of cystic fibrosis, 2019-06, Vol.18, p.S75-S75

Naehrlich, L.

2019

Volltextzugriff (PDF)

WS10.5 Influence of tobacco smoke on CFTR function

Journal of cystic fibrosis, 2017-06, Vol.16, p.S19-S19

2017

Volltextzugriff (PDF)

Importance to question sinonasal symptoms and to perform rhinoscopy and rhinomanometry in cystic fibrosis patients

Pediatric pulmonology, 2017-02, Vol.52 (2), p.167-174

2017

Volltextzugriff (PDF)

Sweat testing practices in German cystic fibrosis centres

Klinische Pädiatrie, 2007-03, Vol.219 (2), p.70-73

Naehrlich, L

2007

Volltextzugriff (PDF)

Sweat testing in CF

Thorax, 2007-05, Vol.62 (5), p.462-462

Naehrlich, Lutz

2007

Volltextzugriff (PDF)

325 Isolated heart transplantation for left heart failure in a CF patient

Journal of cystic fibrosis, 2015-06, Vol.14, p.S141-S141

2015

Volltextzugriff (PDF)

EPS5.2 Genetic epidemiology of CFTR nonsense mutations across Europe

Journal of cystic fibrosis, 2017-06, Vol.16, p.S47-S47

2017

Volltextzugriff (PDF)

S25 Benefits of lumacaftor/ivacaftor (LUM/IVA) initiation in children with CF aged 2 through 5 years: Interim results from an ongoing registry-based study

Thorax, 2023-11, Vol.78 (Suppl 4), p.A22-A22

2023

Volltextzugriff (PDF)

WS11.3 Cystic fibrosis survival and socioeconomic status across Europe

Journal of cystic fibrosis, 2017-06, Vol.16, p.S20-S20

2017

Volltextzugriff (PDF)

WS17.5 Patients with cystic fibrosis and the R117H mutation: The European experience

Journal of cystic fibrosis, 2015-06, Vol.14, p.S32-S32

2015

Volltextzugriff (PDF)

294 Individualized vitamin A supplementation for patients with cystic fibrosis

Journal of cystic fibrosis, 2013-06, Vol.12, p.S123-S123

2013

Volltextzugriff (PDF)

WS3.4 Clostridium difficile, but not Giardia lamblia, is a frequent finding in the stool of CF-patients

Journal of cystic fibrosis, 2013-06, Vol.12, p.S5-S5

2013

Volltextzugriff (PDF)

P120 Utilisation of multiple breath washout in Europe differs substantially between age groups and countries

Journal of cystic fibrosis, 2024-06, Vol.23, p.S122-S122

2024

Volltextzugriff (PDF)

Durchführung und Interpretation des Schweißtests in deutschen Mukoviszidoseambulanzen

Klinische Pädiatrie, 2007-03, Vol.219 (2), p.70-73

Naehrlich, L.

2007

Volltextzugriff (PDF)

WS16.04 Benefits of lumacaftor/ivacaftor (LUM/IVA) initiation in children with cystic fibrosis aged 2 through 5 years: Interim results from an ongoing registry-based study

Journal of cystic fibrosis, 2023-06, Vol.22, p.S30-S31

2023

Volltextzugriff (PDF)

P050 Drug desensitisation for lumacaftor/ivacaftor - step-by-step to drug tolerance

Journal of cystic fibrosis, 2021, Vol.20, p.S53

2021

Volltextzugriff (PDF)

271 Iodine deficiency and subclinical hyperthyroidism are common in cystic fibrosis patients

Journal of cystic fibrosis, 2012-06, Vol.11, p.S125-S125

2012

Volltextzugriff (PDF)

465 Bridging the gap for health inequality in lowincome countries : lessons from cystic fibrosis during the last decade in Europe

Journal of cystic fibrosis, 2024-09, Vol.23, p.S252-S252

2024

Volltextzugriff (PDF)

P122 The quality of the data in the European Cystic Fibrosis Society Patient Registry as assessed through source data verification from 2018 to 2024

Journal of cystic fibrosis, 2024-06, Vol.23, p.S123-S123

2024

Volltextzugriff (PDF)

1 – 25 von 100

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(92)
Mit Volltextzugriff
(87)

Publikationsform

Sprache

Englisch
(75)
Deutsch
(25)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Drug desensitization to lumacaftor/ivacaftor: A fast lane to drug tolerance

Be flexible when unscrewing: Screw aspiration in a 15‐year‐old girl

Chronic inhaled antibiotic therapy in people with cystic fibrosis with Pseudomonas aeruginosa infection in Germany

Risk factors for cystic fibrosis arthropathy: Data from the German cystic fibrosis registry

Concordant genotype of upper and lower airways P aeruginosa and S aureus isolates in cystic fibrosis

ECFS standards of care on CFTR-related disorders: Towards a comprehensive program for affected individuals

P063 Survival analysis of the German Cystic Fibrosis Registry

WS10.5 Influence of tobacco smoke on CFTR function

Importance to question sinonasal symptoms and to perform rhinoscopy and rhinomanometry in cystic fibrosis patients

Sweat testing practices in German cystic fibrosis centres

Sweat testing in CF

325 Isolated heart transplantation for left heart failure in a CF patient

EPS5.2 Genetic epidemiology of CFTR nonsense mutations across Europe

S25 Benefits of lumacaftor/ivacaftor (LUM/IVA) initiation in children with CF aged 2 through 5 years: Interim results from an ongoing registry-based study

WS11.3 Cystic fibrosis survival and socioeconomic status across Europe

WS17.5 Patients with cystic fibrosis and the R117H mutation: The European experience

294 Individualized vitamin A supplementation for patients with cystic fibrosis

WS3.4 Clostridium difficile, but not Giardia lamblia, is a frequent finding in the stool of CF-patients

P120 Utilisation of multiple breath washout in Europe differs substantially between age groups and countries

Durchführung und Interpretation des Schweißtests in deutschen Mukoviszidoseambulanzen

WS16.04 Benefits of lumacaftor/ivacaftor (LUM/IVA) initiation in children with cystic fibrosis aged 2 through 5 years: Interim results from an ongoing registry-based study

P050 Drug desensitisation for lumacaftor/ivacaftor - step-by-step to drug tolerance

271 Iodine deficiency and subclinical hyperthyroidism are common in cystic fibrosis patients

465 Bridging the gap for health inequality in lowincome countries : lessons from cystic fibrosis during the last decade in Europe

P122 The quality of the data in the European Cystic Fibrosis Society Patient Registry as assessed through source data verification from 2018 to 2024

Suchergebnisse filtern